{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:44:53Z","timestamp":1790639093034,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijid.2020.03.029","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T14:05:42Z","timestamp":1584367542000},"page":"464-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future\u2026"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-9890","authenticated-orcid":false,"given":"Guillaume","family":"Desoubeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Lemaignen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2020.03.029_bib0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10096-005-0065-z","article-title":"Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation","volume":"25","author":"Annaloro","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.135350","article-title":"A trial of caspofungin salvage treatment in PCP pneumonia","volume":"66","author":"Armstrong-James","year":"2011","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0015","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.40.8.1811","article-title":"Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo","volume":"40","author":"Bartlett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2020.03.029_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2006-933433","article-title":"Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia","volume":"218","author":"Beltz","year":"2006","journal-title":"Klin Padiatr"},{"issue":"17","key":"10.1016\/j.ijid.2020.03.029_bib0025","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/QAD.0b013e32834c4c3c","article-title":"Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jirovecii pneumonia","volume":"25","author":"Ceballos","year":"2011","journal-title":"AIDS Lond Engl"},{"issue":"1","key":"10.1016\/j.ijid.2020.03.029_bib0030","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of Pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2020.03.029_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1439-0507.2008.01530.x","article-title":"Pneumocystis jiroveci pneumonia in a patient with Wegener\u00fcs granulomatosis treated efficiently with caspofungin","volume":"51","author":"Hof","year":"2008","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.ijid.2020.03.029_bib0040","first-page":"3227","article-title":"Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: a case report","volume":"16","author":"Huang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ijid.2020.03.029_bib0045","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","author":"Huang","year":"2019","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.ijid.2020.03.029_bib0050","first-page":"141","article-title":"High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of caspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia","volume":"88","author":"Jin","year":"2019","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2020.03.029_bib0055","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/508282","article-title":"Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy","volume":"43","author":"Kamboj","year":"2006","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/00365548.2012.760842","article-title":"Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review","volume":"45","author":"Kim","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.029_bib0065","doi-asserted-by":"crossref","first-page":"e00496","DOI":"10.1016\/j.idcr.2019.e00496","article-title":"Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia","volume":"15","author":"Koshy","year":"2019","journal-title":"IDCases"},{"key":"10.1016\/j.ijid.2020.03.029_bib0070","first-page":"2017","article-title":"HIV-related Pneumocystis jirovecii pneumonia managed with caspofungin and veno-venous extracorporeal membrane oxygenation rescue therapy","author":"Lee","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.ijid.2020.03.029_bib0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jmii.2016.03.008","article-title":"Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia","volume":"50","author":"Lee","year":"2017","journal-title":"J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi"},{"issue":"1","key":"10.1016\/j.ijid.2020.03.029_bib0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12890-016-0307-0","article-title":"Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review","volume":"16","author":"Li","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0085","doi-asserted-by":"crossref","first-page":"e70619","DOI":"10.1371\/journal.pone.0070619","article-title":"Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice","volume":"8","author":"Lobo","year":"2013","journal-title":"PloS ONE"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0090","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.transproceed.2017.04.020","article-title":"Combination of echinocandins and trimethoprim\/sulfamethoxazole for the treatment of Pneumocystis jiroveci pneumonia after heart transplantation","volume":"49","author":"Lu","year":"2017","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.ijid.2020.03.029_bib0095","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0100","first-page":"996","article-title":"Caspofungin in salvage treatment of severe Pneumocystis pneumonia: case report and literature review","volume":"122","author":"Mu","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"10.1016\/j.ijid.2020.03.029_bib0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01296-19","article-title":"Caspofungin and Pneumocystis pneumonia: it is time to go ahead","volume":"63","author":"Nevez","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0110","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.42.8.1985","article-title":"Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii","volume":"42","author":"Powles","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.38.6.1397","article-title":"Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats","volume":"38","author":"Powles","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0120","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.39.6.1320","article-title":"New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat","volume":"39","author":"Schmatz","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0125","first-page":"151S","article-title":"Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329","volume":"38","author":"Schmatz","year":"1991","journal-title":"J Protozool"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jiac.2017.02.008","article-title":"Caspofungin versus micafungin in the incidence of hepatotoxicity in patients with normal to moderate liver failure","volume":"23","author":"Shibata","year":"2017","journal-title":"J Infect Chemother Off J Jpn Soc Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2020.03.029_bib0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/mmy\/myu060","article-title":"Efficacy of caspofungin, a 1,3-\u03b2-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats","volume":"52","author":"Sun","year":"2014","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.ijid.2020.03.029_bib0140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12133","article-title":"Combination of caspofungin and low-dose trimethoprim\/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients","volume":"18","author":"Tu","year":"2013","journal-title":"Nephrol Carlton Vic"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.tp.0000280546.91617.6c","article-title":"Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe Pneumocystis pneumonia in solid organ transplant recipients","volume":"84","author":"Utili","year":"2007","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ijid.2020.03.029_bib0150","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1517\/13543784.16.6.899","article-title":"The use of caspofungin in HIV-infected individuals","volume":"16","author":"Waters","year":"2007","journal-title":"Expert Opin Investig Drugs ."},{"issue":"5","key":"10.1016\/j.ijid.2020.03.029_bib0155","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1378\/chest.128.5.3711","article-title":"Suitability of caspofungin for aerosol delivery: physicochemical profiling and nebulizer choice","volume":"128","author":"Wong-Beringer","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ijid.2020.03.029_bib0160","first-page":"246","article-title":"Lack of response in severe pneumocystis pneumonia to combined caspofungin and clindamycin treatment: a case report","volume":"26","author":"Yao","year":"2011","journal-title":"Chin Med Sci J Chung-Kuo Hsueh Ko Hsueh Tsa Chih"},{"issue":"2","key":"10.1016\/j.ijid.2020.03.029_bib0165","first-page":"1594","article-title":"Efficacy of caspofungin combined with trimethoprim\/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"issue":"7","key":"10.1016\/j.ijid.2020.03.029_bib0170","first-page":"463","article-title":"[The treatment of Pneumocystis carinii pneumonia with caspofungin in elderly patients: a case report and literature review]","volume":"29","author":"Zhang","year":"2006","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122030148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122030148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:54:08Z","timestamp":1761119648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122030148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"alternative-id":["S120197122030148X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.029","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future\u2026","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}